article thumbnail

STAT+: Backed by Mayo Clinic and Microsoft, a nonprofit forms to test AI tools used in health care

STAT

The nonprofit will establish the laboratories at Mayo Clinic, Duke, Stanford, and other major universities and institutions around the country. Its goal is to create a system to certify and register AI models, and publish details about their performance before they are widely adopted.

article thumbnail

STAT+: FDA clears digital stethoscope company’s AI algorithm for heart failure

STAT

The stethoscope is the result of a collaboration between Mayo Clinic researchers, who built the algorithm, and the startup Eko Health, which built the hardware. Mayo Clinic is an investor in Eko, which has raised $128 million over the past six years.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Industry group says FDA botched COVID-19 convalescent plasma guidance

pharmaphorum

Already under fire for what some view as a premature authorisation of convalescent plasma for COVID-19, the FDA is now being accused of a blunder that could render current supplies unusable. The post Industry group says FDA botched COVID-19 convalescent plasma guidance appeared first on.

FDA 105
article thumbnail

Startup Neuroglee raises $10m for virtual neurology clinics

pharmaphorum

A digital health company focusing on neurodegenerative disorders – Neuroglee Therapeutics – has raised $10 million in first-round funding to roll out a virtual neurology clinics for people with cognitive problems caused by dementia. The post Startup Neuroglee raises $10m for virtual neurology clinics appeared first on.

article thumbnail

Treatment options for Crohn’s disease expand after Rinvoq approval

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has approved AbbVie’s Rinvoq (upadacitinib) for patients with Crohn’s disease who do not respond to TNF blockers, a common immune suppressant treatment for the condition. Clinical response was observed after just two weeks in some cases.

article thumbnail

False positives with Apple Watch could tie up health resources

pharmaphorum

A study of people who consulted a doctor after an abnormal pulse was detected by their device suggests it could lead to false positives that mean unnecessary healthcare visits, according to the team from the Mayo Clinic. Stricter access controls are encouraged to ensure real-world use conforms with FDA guidance,” they add.

article thumbnail

AI-powered stethoscope from Eko spots heart failure in seconds

pharmaphorum

” The algorithm used in the stethoscope is a modification of one developed by the Mayo Clinic in the US for a 12-lead ECG, that was modified to apply it to the single lead version. Eko says it will be submitted to the FDA for approval later his year. This means better and more cost-effective healthcare.”